J
Jörg Hausleiter
Researcher at Ludwig Maximilian University of Munich
Publications - 380
Citations - 22635
Jörg Hausleiter is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 65, co-authored 295 publications receiving 18419 citations. Previous affiliations of Jörg Hausleiter include Alliance University & Technische Universität München.
Papers
More filters
Journal ArticleDOI
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Jörg Fuhrmann,Michael Böhm,Henning Ebelt,Steffen Schneider,Gerhard Schuler,Karl Werdan +18 more
TL;DR: The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned.
Journal ArticleDOI
Estimated Radiation Dose Associated With Cardiac CT Angiography
Jörg Hausleiter,Tanja Meyer,Franziska Hermann,Martin Hadamitzky,Markus Krebs,Thomas C. Gerber,Cynthia H. McCollough,Stefan Martinoff,Adnan Kastrati,Albert Schömig,Stephan Achenbach +10 more
TL;DR: In this article, a cross-sectional, international, multicenter, observational study was conducted to estimate the radiation dose of CCTA in routine clinical practice as well as the association of currently available strategies with dose reduction.
Journal Article
Estimated Radiation Dose Associated With Cardiac CT Angiography. Commentary
Jörg Hausleiter,Tanja Meyer,Franziska Hermann,Martin Hadamitzky,Markus Krebs,Thomas C. Gerber,Cynthia H. McCollough,Stefan Martinoff,Adnan Kastrati,Albert Schömig,Stephan Achenbach,Andrew J. Einstein +11 more
TL;DR: The comparable diagnostic image quality of CCTA may support an increased use of dose-saving strategies in adequately selected patients and effective strategies to reduce radiation dose are available but some strategies are not frequently used.
Journal ArticleDOI
Percutaneous Mitral Valve Interventions in the Real World: Early and 1-Year Results From the ACCESS-EU, A Prospective, Multicenter, Nonrandomized Post-Approval Study of the MitraClip Therapy in Europe
Francesco Maisano,Olaf Franzen,Stephan Baldus,Ulrich Schäfer,Jörg Hausleiter,Christian Butter,Gian Paolo Ussia,Horst Sievert,Gert Richardt,Julian D. Widder,Tiziano Moccetti,Wolfgang Schillinger +11 more
TL;DR: In the real-world, post-approval experience in Europe, patients undergoing the MitraClip therapy are high-risk, elderly patients, mainly affected by functional MR, and in this patient population, the MitRAClip procedure is effective with low rates of hospital mortality and adverse events.
Journal ArticleDOI
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Antoinette de Waha,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Bernward Lauer,Michael Böhm,Henning Ebelt,Steffen Schneider,Karl Werdan,Gerhard Schuler +19 more
TL;DR: In patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, IABP did not reduce 12 month all-cause mortality.